Stimulation of mucosal inflammatory activity by the normal fecal flora in a rat model of colitis

Inflammatory Bowel Diseases

Volumn 3, Issue 3, 1997, Pages 191-197

  Videla, Sebastián ^a   Vilaseca, Jaime ^a   Guarner, Francisco ^a,c   Salas, Antonio ^b   Gonzalez G ^b   Antolín, Maria ^a   Malagelada, Juan R ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Bacteria; Inflammation; Leukotrienes; Prostaglandins; Trinitrobenzenesulfonic acid

Indexed keywords

EID: 0001570078     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780030304     Document Type: Article

References (23)

1. Sartor RB, Cromartie WJ, Powell D, Schwab JH. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology 1985;89:587-95.
2. Robert A, Asano T. Resistance of germ-free rats to indomethacin induced intestinal lesions. Prostaglandins 1977;14:333-41.
3. Kent TH, Cardelli RM, Stamier FW. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol 1969;34: 237-45.
4. Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 1993;17:641-62.
5. Onderdonk AB, Bartlett JG. Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr 1979;32:258-65.
6. Onderdonk AB, Cisneros RL, Bronson RT. Enhancement of experimental ulcerative colitis by immunization with Bacteroides vulgatus. Infect Immun 1983;42:783-8.
7. Onderdonk AB, Steeves RM, Cisneros RL, Bronson RT. Adoptive transfer of immune enhancement of experimental ulcerative colitis. Infect Immun 1984;46:64-7.
8. Onderdonk AB, Hermos JA, Dzink JL, Bartlett JG. Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology 1978;74:521-6.
9. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
10. Videla S, Vilaseca J, Guarner F, Salas A, Treserra F, Crespo E, Antol M, Malagelada JR. Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. Gut 1994;35:1090-7.
11. Vilaseca J, Salas A, Guarner F, Rodr Alguez R, Malagelada J-R. Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis. Gastroenterology 1990;98:269-77.
12. Chadwick VS, Anderson RP. Microorganisms and their products in inflammatory bowel disease. In: McDermott RP, Stenson WF, eds. Inflammatory bowel disease. New York: Elsevier, 1992:241-58.
13. Sartor RB. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation. In: Kirsner JB, Shorter RJ, eds. Inflammatory bowel disease. Baltimore: Williams & Wilkins, 1995:64-75.
14. lo T cells. Res Immunol 1994;145:357-62.
15. Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180:2359-64.
16. Sadlack B, Merz H, Schorle H, Schimpl A, Feller A, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
17. Kuhn R, Löhler J, Rennick D, Rajewski K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
18. De Simone C, Vesely R, Bianchi SB, Jirillo E. The role of probiotics in modulation of the immune system in man and animals. Int J Immunother 1993;9:23-8.
19. Roberfroid MB, Bornet F, Bouley C, Cummings JH. Colonic microflora: nutrition and health. Nutr Rev 1995;53:127-30.
20. Kunin S, Gallily R. Recognition and lysis of altered self cells by macrophages, a modification of target cells by 2,4,6-trinitrobenzene sulfonic acid. Immunology 1983;121:1711-8.
21. Morris GP, Beck PL, Herridge MS, Depew WT, Szewezuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
22. Appleyard CB, Wallace JL. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol 1995; 269:0119-25.
23. Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjamason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996;38:365-75.